ニュース

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
従来プロセスなら承認まで平均10〜12か月。FDAのAI導入がフル稼働すれば、承認期間は最短3か月になるかもしれない。エミリーの家族にとって、その9か月の短縮は“命そのもの”だ。 AIは何をする? 5秒でわかる技術メニュー **EMA(欧州医薬品庁)**が ...
アメリカ食品医薬品局には、市販薬と処方薬の審査を担当する部局として「医薬品評価研究センター (CDER)」という部署があり、「cderGPT」という名称はCDERから取られたものと考えられます。 Center for Drug Evaluation ...
The Food and Drug Administration is going all in on artificial intelligence. Commissioner Martin Makary, M.D., has instructed all the agency’s centers to fully integrate generative AI into their ...
Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...
Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...
Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of constantly ...
Following a pilot on generative AI tools’ efficacy in aiding scientific reviews, FDA Commissioner Martin Makary announced the deployment of the finalized version of the software across the ...